Goni Katz-Greenberg1,2, Michael Malinchoc3, Dennis L Broyles3, David Oxman4, Seyed M Hamrahian2, Omar H Maarouf2. 1. Division of Nephrology, Department of Medicine, Duke University Medical Center, Durham, North Carolina. 2. Renal Division, Thomas Jefferson University Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania. 3. L3Healthcare LLC, San Diego, California. 4. Pulmonary Division, Thomas Jefferson University Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania.
Abstract
Background: Acute kidney injury (AKI) is most commonly caused by tubular injury and is associated with a wide variety of critical illnesses. It is well known that urinary biomarkers can lead to the early identification of AKI. However, the ability of urinary biomarkers to distinguish between different types of critical illness has been less studied. Methods: In this prospective cohort study, urinary neutrophil gelatinase-associated lipocalin (uNGAL) was measured in 107 patients consecutively admitted to the ICUs in our tertiary medical center. uNGAL samples were collected within 3-6 hours of admission to an ICU and measured by ELISA. All data were analyzed using R statistical software, and univariate analysis was used to determine the correlations of uNGAL levels with AKI stage, admission diagnoses, and ICU course. Results: uNGAL level increased by a mean of 24-fold (SD 10-59) in ICU patients with AKI and demonstrated a significant correlation with the different AKI stages. uNGAL predicted the need for RRT, with values increased by more than 15-fold (P<0.05) in patients needing RRT, and remained a useful tool to predict AKI in ICU patients with a urinary tract infection. uNGAL level was correlated with certain ICU admitting diagnoses whereby uNGAL levels were lower in ICU patients with cardiogenic shock compared with other admission diagnoses (β=-1.92, P<0.05). Conclusions: uNGAL can be used as an early predictor of AKI and its severity in patients admitted to the ICU, including the need for RRT. uNGAL may also help in distinguishing patients with cardiogenic shock from those with other critical illnesses and identifying those at risk for poor outcomes irrespective of the presence of AKI.
Background: Acute kidney injury (AKI) is most commonly caused by tubular injury and is associated with a wide variety of critical illnesses. It is well known that urinary biomarkers can lead to the early identification of AKI. However, the ability of urinary biomarkers to distinguish between different types of critical illness has been less studied. Methods: In this prospective cohort study, urinary neutrophil gelatinase-associated lipocalin (uNGAL) was measured in 107 patients consecutively admitted to the ICUs in our tertiary medical center. uNGAL samples were collected within 3-6 hours of admission to an ICU and measured by ELISA. All data were analyzed using R statistical software, and univariate analysis was used to determine the correlations of uNGAL levels with AKI stage, admission diagnoses, and ICU course. Results: uNGAL level increased by a mean of 24-fold (SD 10-59) in ICU patients with AKI and demonstrated a significant correlation with the different AKI stages. uNGAL predicted the need for RRT, with values increased by more than 15-fold (P<0.05) in patients needing RRT, and remained a useful tool to predict AKI in ICU patients with a urinary tract infection. uNGAL level was correlated with certain ICU admitting diagnoses whereby uNGAL levels were lower in ICU patients with cardiogenic shock compared with other admission diagnoses (β=-1.92, P<0.05). Conclusions: uNGAL can be used as an early predictor of AKI and its severity in patients admitted to the ICU, including the need for RRT. uNGAL may also help in distinguishing patients with cardiogenic shock from those with other critical illnesses and identifying those at risk for poor outcomes irrespective of the presence of AKI.
Authors: Jacob C Jentzer; Patrick R Lawler; Sean van Diepen; Timothy D Henry; Venu Menon; David A Baran; Vladimír Džavík; Gregory W Barsness; David R Holmes; Kianoush B Kashani Journal: Circ Cardiovasc Qual Outcomes Date: 2020-12-07
Authors: Edward D Siew; Lorraine B Ware; Tebeb Gebretsadik; Ayumi Shintani; Karel G M Moons; Nancy Wickersham; Frederick Bossert; T Alp Ikizler Journal: J Am Soc Nephrol Date: 2009-07-23 Impact factor: 10.121
Authors: Christian Albert; Antonia Zapf; Michael Haase; Christian Röver; John W Pickering; Annemarie Albert; Rinaldo Bellomo; Tobias Breidthardt; Fabrice Camou; Zhongquing Chen; Sidney Chocron; Dinna Cruz; Hilde R H de Geus; Prasad Devarajan; Salvatore Di Somma; Kent Doi; Zoltan H Endre; Mercedes Garcia-Alvarez; Peter B Hjortrup; Mina Hur; Georgios Karaolanis; Cemil Kavalci; Hanah Kim; Paolo Lentini; Christoph Liebetrau; Miklós Lipcsey; Johan Mårtensson; Christian Müller; Serafim Nanas; Thomas L Nickolas; Chrysoula Pipili; Claudio Ronco; Guillermo J Rosa-Diez; Azrina Ralib; Karina Soto; Rüdiger C Braun-Dullaeus; Judith Heinz; Anja Haase-Fielitz Journal: Am J Kidney Dis Date: 2020-07-15 Impact factor: 8.860
Authors: Seung Seok Han; Sejoong Kim; Shin Young Ahn; Jeonghwan Lee; Dong Ki Kim; Ho Jun Chin; Dong-Wan Chae; Ki Young Na Journal: BMC Nephrol Date: 2013-06-27 Impact factor: 2.388
Authors: Azrina Md Ralib; John W Pickering; Geoffrey M Shaw; Martin P Than; Peter M George; Zoltán H Endre Journal: Crit Care Date: 2014-11-04 Impact factor: 9.097
Authors: Amay Parikh; John A Rizzo; Pietro Canetta; Catherine Forster; Meghan Sise; Omar Maarouf; Eugenia Singer; Antje Elger; Saban Elitok; Kai Schmidt-Ott; Jonathan Barasch; Thomas L Nickolas Journal: PLoS One Date: 2017-09-27 Impact factor: 3.240
Authors: Christine K Federspiel; Theis S Itenov; Kala Mehta; Raymond K Hsu; Morten H Bestle; Kathleen D Liu Journal: Ann Intensive Care Date: 2018-02-23 Impact factor: 6.925